Global Presence Meda AB has an extensive international footprint, selling products in over 150 countries and maintaining own organizations in more than 60 markets, presenting opportunities to tailor and expand global partnerships.
Acquisition Momentum Being acquired by Mylan in 2016 indicates Meda’s strategic value and potential integration with a major global player, which may open avenues for joint product development and expanded distribution channels.
Product Specialty As a specialty pharma company, Meda focuses on niche therapeutic areas, suggesting sales potential with healthcare providers and pharmacies seeking specialized pharmaceutical solutions.
Emerging Market Entry With limited current revenue figures but significant international reach, there is considerable opportunity to introduce innovative or complementary products to Meda’s existing distribution network.
Technology Utilization Meda employs a range of digital tools including SiteCatalyst and Adobe Tag Manager, indicating openness to adopting new digital marketing strategies and sales enablement technologies to identify and convert prospects.
$50M$100M
$1B$10B
$10B
$1B$10B
$250M$500M
$100M$250M
$100M$250MMeda AB uses 6 technology products and services including SiteCatalyst, TYPO3, jQuery, and more. Explore Meda AB's tech stack below.
| Meda AB Email Formats | Percentage |
| First.Last@meda.se | 92% |
| Last.First@meda.se | 5% |
| FirstL@meda.se | 1% |
| F.Last@meda.se | 2% |
Pharmaceutical Manufacturing0-1 Employees
MEDA AB (publ) is a leading international specialty pharma company. Meda’s products are sold in more than 150 countries worldwide and the company is represented by its own organizations in over 60 countries. The Meda share is listed under Large Cap on Nasdaq Stockholm. Find out more, visit www.meda.se.
Company Overview
Funding & FinancialsMeda AB's revenue is estimated to be in the range of $1M
Funding & FinancialsMeda AB's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com